Introduction c-jun encodes the major component of the sequencespeci®c transcriptional activator protein AP1. In cooperation with another oncogene such as an activated Ras, c-Jun is able to transform primary rat embryo ®broblasts (REF) . In order to better understand the molecular mechanisms involved in cellular transformation by c-Jun, we constructed a dierential cDNA library to identify new target genes for this transcription factor. Among the genes whose expression was regulated by c-Jun, we found three genes coding for extracellular matrix proteins: SPARC, thrombospondin 1 (TSP1) (Mettouchi et al., 1994) and tenascin-C (Mettouchi et al., 1997) .
TSP1 is a platelet-and cell-derived homotrimeric glycoprotein of M r 450 000 and is secreted in a wide range of tissues where it is bound to the extracellular matrix. TSP1 is able to bind a large variety of proteins including several receptors, enzymes, cytokines and other extracellular matrix proteins (Bornstein, 1995) . Due to these multiple interactions, TSP1 has been shown to be implicated in development, in¯ammation, wound healing, platelet aggregation, coagulation, tumor growth and metastasis. Many, but not all, transformed cell lines express very low levels of TSP1 (Mettouchi et al., 1994; Salnikow et al., 1994; Slack and Bornstein, 1994; Sheibani and Frazier, 1996; Tikhonenko et al., 1996) . In some cases, re-expression of TSP1 in transformed cells suppresses their tumorigenicity (Weinstat et al., 1994; Sheibani and Frazier, 1995) .
The eect of TSP1 on tumor growth could result from its capacity to inhibit angiogenesis; thus TSP1 inhibits basic ®broblast growth factor-induced angiogenesis in a rat cornea model (Tolsma et al., 1993) , exogenously added TSP1 blocks the ability of cultured capillary endothelial cells to organize into cords (Tolsma et al., 1997) , and down regulation of endothelial TSP1 enhances angiogenesis in vitro (DiPietro et al., 1994) . Good evidence for an antiangiogenic eect of TSP1 in vivo is provided by a recent study showing that the tumorigenicity of human ®brosarcomas and B16 melanomas in nude mice varied inversely with the level of TSP1 produced by the ®brosarcomas or provided exogenously (Volpert et al., 1998) . However, some investigators attribute proangiogenic properties to TSP1 in vitro (Castle et al., 1993; Clezardin et al., 1993; Qian and Tuszynski, 1996; Bertin et al., 1997) or propose that varying eects could be obtained depending on the concentration of TSP1 (Qian et al., 1997) . The interaction of TSP1 with Integrin-associated protein (IAP) which has been shown to increase the spreading of endothelial cells (Gao et al., 1996) could perhaps account for such proangiogenic eects in vitro.
In a previous study we have shown that the transcription factor c-Jun, negatively regulates the transcription of TSP1 (Mettouchi et al., 1994) . In this study, we show that this repression occurs by an indirect mechanism involving a factor secreted (or activated) by c-Jun over-expressing cells. This factor activates the binding of the transcription factor WT1 to the 7210 region of the TSP1 promoter, resulting in the repression of TSP1 transcription.
Wilms' tumor is a pediatric kidney cancer. Analysis of children with genetic susceptibility to this cancer led to the isolation of a tumor-suppressor gene termed Wilms' Tumor gene 1, WT1 (Haber et al., 1990) . This gene encodes a transcription factor with four DNAbinding zinc ®ngers at its C-terminus and a prolineand glutamine-rich transactivation domain at the Nterminus. The gene is composed of ten exons and, due to two alternative splice sites, four isoforms of the protein are present in constant relative proportion in normal tissues (Reddy and Licht, 1996) . The alternative splice site I, corresponds to the insertion of 17 amino acids between the transactivation and the DNAbinding domain. Its function is not clearly de®ned. The alternative splice II, which is present in about 80% of WT1 transcripts, leads to the insertion of three amino acids, KTS, between zinc ®ngers 3 and 4. The biology of WT1 is thus complex. Two main functions are assigned to this protein: in regulation of initiation of transcription, and in RNA processing. WT1, which colocalizes with spliceosomes in the nucleus, could participate in mRNA processing since a mRNAbinding sequence has been identi®ed in WT1 (Larsson et al., 1995; Caricasole et al., 1996) .
Although the role of WT1 as a transcription factor has been studied in more detail, the consensus DNA sequence for WT1 binding is not clear. Several groups, using dierent approaches have de®ned consensus sequences for the WT17KTS and +KTS isoforms, (Hamilton et al., 1995 (Hamilton et al., , 1998 Nakagama et al., 1995; Hewitt et al., 1996) . All these sequences are G-C rich but they dier somewhat, even in the length of the consensus which varies from 9 ± 12 bp and they all accept several variations. The anities of each WT1 isoform for these dierent DNA-binding sites vary. Furthermore, most of the`consensus' sequences determined are able to bind EGR1 and some bind both EGR1 and SP1, two other zinc ®nger transcription factors. In addition, WT1, EGR1 and SP1 DNA binding capacities are regulated by phosphorylation (Cao et al., 1993; Ye et al., 1996; Sakamoto et al., 1997) . In this study, we found that among the three zinc ®nger proteins potentially able to bind to the 7210 region of the TSP1 promoter, WT1 is the only one that binds in response to c-Jun overexpression and mediates TSP1 repression thus exhibiting oncogenic properties.
Results

TSP1 repression by c-Jun is transcriptional and is mediated by a secreted factor
We had previously shown that transient overexpression of c-Jun represses TSP1 mRNA in rat embryo ®broblasts (REF) and in FR3T3, an immortalized cell line derived spontaneously from REF cells. TSP1 repression is also observed in FR3T3 cells transformed by constitutive overexpression of c-Jun (Mettouchi et al., 1994) . In one of these c-Jun-transformed cell lines, cJ4, the TSP1 mRNA level was reduced to 15% of that in FR3T3 cells (Figure 1a) . However, repression of TSP1 is not a general side eect of transformation since some oncogenes such as bovine papilloma viral oncogenes are also able to transform FR3T3 cells (RV145-4 cell line) but do not induce TSP1 repression (Figure 1a) .
The aim of this study was to determine the mechanisms of TSP1 repression by c-Jun. To better study TSP1 transcription, we constructed a reporter plasmid in which the region extending from 72800 to +47 of the mouse TSP1 promoter (Bornstein et al., 1990) controls the transcription of the secreted alkaline phosphatase (SEAP) coding sequence. This construct is named 72800 TSP1 ± SEAP in this paper. SEAP activity is measured in cell culture medium of transfected cells with a sensitive luminometric assay and the stability of the protein allows accurate kinetic experiments. This 72800 TSP1 ± SEAP construct was transiently transfected into FR3T3, alone or in cotransfection with a RSV-c-Jun expression vector. In c-Jun transfected cells, its activity was reduced to 21+10% (mean+s.e.m., n=7) of control values (Figure 1b) suggesting that this sequence includes the elements involved in the repression. An HSV7TK-luciferase vector was transfected in parallel experiments to verify that this did not re¯ect a general inhibition of transcription (data not shown). In addition, the activation of the endogenous c-Jun protein resulted in a similar level of repression of the TSP1 promoter activity; treatment of 72800 TSP1 ± SEAP transfected Northern blot analysis was performed using mRNA from FR3T3, cJ4, or RV145-4 cell lines. Blots were hybridized with a TSP1 probe and quanti®ed with a phosphor imager (mean+s.e.m., n=3). Values are normalized to S26 mRNA level and given as percentage of FR3T3 level. (b) FR3T3 were transfected with the 72800 TSP1 ± SEAP reporter vector, alone or cotransfected with an RSV c-Jun or an RSV ± GCN4 expression vector (10 mg/10 6 cells). After transfection, cells were maintained for 24 h in DMEM-0.5% NBS before measuring SEAP activity. TPA (100 ng/ml) and anisomycin (25 ng/ml) were added in the medium 24 h and 4 h, respectively, before measuring the reporter activity. Values represent SEAP activity compared to the control value (100%). Values are mean+s.e.m. of seven independent experiments performed in triplicate except for GCN4 (n=3). (c) TSP1 transcription levels in cells treated with CM-cJ4 or CM-RV145-4. FR3T3 cells were transfected with the 72800 TSP1 ± SEAP reporter vector. After transfection, cells were trypsinized and replated in DMEM-0.5% NBS, diluted 1 : 2 or not with conditioned medium of cJ4 or RV145-4 cell lines. SEAP activity was measured 24 h later. Values are compared to the DMEM 0.5% control value cells with anisomycin, a c-Jun kinase activator (Cano et al., 1994) , or with TPA, leading to c-Jun activation via the protein kinase C pathway, repressed the reporter activity to 22+3% (n=5) or 31+9% (n=5) of control values respectively (Figure 1b) . In contrast, the yeast GCN4 transcription factor which binds to sequences highly homologous to mammalian AP1 sequences (Struhl, 1987) , but does not transform cells, had little, if any, eect on the TSP1 promoter (Figure 1b) .
In previous experiments we had shown that the high level of repression of the TSP1 gene observed in c-Jun transfection experiments was, at least in part, due to a factor secreted in the medium by cells overexpressing cJun. Consequently, TSP1 expression was repressed even in non-transfected cells (Mettouchi et al., 1994) . To con®rm that this repression was transcriptional, conditioned media from cells transformed by c-Jun, cJ4 cells (CM-cJ4), were tested on the TSP1 ± SEAP reporter and showed a marked (90%) inhibition of SEAP activity as compared to control levels ( Figure  1c ). In contrast, conditioned media from the RV145-4 transformed cell line induced only a moderate repression. To determine some biochemical characteristics of the secreted factor present in CM-cJ4, we tested its resistance to alkali or acids and observed that its capacity to repress TSP1 transcription was enhanced by acidi®cation of the medium to pH 3.5, followed immediately by neutralization. This ®nding suggests the necessity of an eventual proteolytic cleavage of the secreted factor to activate it. Therefore, all experiments involving conditioned medium from CJ4 or other cell lines were performed with acidi®ed-neutralized conditioned or control media.
Northern blot experiments were performed to determine if de novo protein synthesis was necessary for CM-cJ4-driven repression of TSP1. For that purpose, FR3T3 cells were incubated in control medium or in CM-cJ4 in the presence or absence of cycloheximide, a protein synthesis inhibitor. Northern blot analysis of TSP1 mRNA levels was then performed (Figure 2). As previously described (Majack et al., 1987) , we observed a twofold induction of TSP1 mRNA levels by cycloheximide treatment. TSP1 mRNA was reduced to the same level in cells treated with CM-cJ4 alone (36% of control level) or in the presence of cycloheximide (40% of control level), indicating that the signal transduction pathway from the secreted factor present in CM-cJ4 to TSP1 gene does not involve de novo protein synthesis.
The repression of TSP1 is mediated by the (7239 to 7135) region of the mouse promoter
In order to determine which sequences of the promoter were involved in the TSP1 repression induced by c-Jun, we used deletion mutants of the 72800 TSP1 ± SEAP vector. To compare the basal transcription level between the dierent constructs, a (72800 to +47) TSP-luciferase vector was cotransfected with dierent SEAP constructs and used as an internal control for transfection eciency. Each TSP ± SEAP construct was analysed for its ability to be repressed by c-Jun in cotransfection experiments (Figure 3 ) or by CM-cJ4 treatment (not shown), and the two treatments gave similar results. Deletion of the (72800 to 7239)TSP1 promoter region did not modify the basal transcription level or its ability to be repressed by CM-cJ4 ( Figure  3a ). However, further deletion, up to 7135, reduced the basal transcription level to 16% of that observed with the 72800 construct and abolished the response to CM-cJ4 treatment or c-Jun overexpression. A shorter construct (741 to +47) showed only a small residual level of transcription. The (784 to 758) region, containing an overlapping EGR1 and Sp1 site was shown to regulate positively the activity of the gene in mouse NIH3T3 cells (Shingu and Bornstein, 1994) . To evaluate the role of this element in our cell system, two reporter constructs, containing a deletion of the (784 to 758) region, or a 3 bp mutation (CCC-TAT) in the EGR1/SP1 site (noted m0 in Figure 3a) , were assayed. In FR3T3, the transcriptional activity of these two reporter constructs was comparable to the level obtained with the longest construct, 72800 TSP1 ± SEAP, and both were repressed by c-Jun overexpression or by CM-cJ4. Therefore, in rat ®broblasts, the (784 to 758) region does not seem to be implicated in the level of basal transcription or in TSP1 repression by c-Jun or CM-cJ4.
To analyse further the role of the (7239 to 7135) region, we cloned it upstream from a heterologous HSV ± TK promoter controlling luciferase transcription. In this context, the (7239 to 7135) region appeared to be sucient to confer sensitivity to either c-Jun overexpression (Figure 3b ) or CM-cJ4 treatment (not shown).
A WT1 site is responsible for the repressive eect of CM-cJ4
Protein binding to the c-Jun responsive sequence (7239 to 7135) was analysed by electrophoretic mobility shift assay (EMSA). Three overlapping fragments of the sequence were used as probes in EMSA. Speci®c band shifts were observed only with a probe encompassing nucleotides 7239 to 7199 (data not shown). Three double-stranded oligonucleotides covering this region were then synthesized and used as Figure 2 Eect of CM-cJ4 in the presence of cycloheximide. FR3T3 were serum-starved for 48 h and then grown for 4 h in DMEM-0.5%NBCS, diluted 1 : 2 or not with CM-cJ4 in the presence or absence of cycloheximide (35 mM). Cells were harvested and RNA was prepared and analysed by Northern blot using a TSP1 probe. Quanti®cation was performed with a phosphorimager. Values (mean+s.e.m., n=3) are normalized to S26 mRNA levels Repression of thrombospondin 1 expression by WT1 V Dejong et al Figure 3 Analysis of the mTSP1 promoter. (a) Dierent regions of the mouse TSP1 promoter were placed 5' to the SEAP coding sequence. The resulting vectors were cotransfected in FR3T3 cells with a (72800 to +47) TSP1-luciferase vector in the presence or absence of a RSV-c-Jun expression vector. SEAP and luciferase activities were measured 24 h after transfection. The graph presents a typical result of an experiment, which was repeated at least ®ve times. Luciferase activity was used to compare the basal activity of each construct to that of (72800 to +47) which was considered to be 100%. Bars represent SEAP activities in the presence of RSVc-Jun (hatched bars) or in control cells (plain bars). The m0 mutation replaces CCC in 772 to 770 by TAT in the TSP1 promoter. (b) the (7239 to 7135) TSP1 region was cloned upstream from the heterologous HSV ± TK promoter and transfected into FR3T3, alone or with a RSV-c-Jun vector. Luciferase activity was measured 24 h after transfection (bold face) in this 22 bp sequence, 5'gctGCGTGGGCGGAGacctatt. Therefore, doublestranded oligonucleotides containing consensus binding sites for EGR1 only (E) or SP1 only (S) were used in competition experiments to test the nature of the band shift components. The C1 complex was displaced, by the SP1 oligonucleotide (Figure 4b lane 2) , while the C2 complex was disrupted by an excess of an EGR1 oligonucleotide (lane 3). Competition with an SP1 oligonucleotide increased the binding to the WT1/ EGR1 site and vice-versa, most likely due to the overlapping positions of the binding sites. An oligonucleotide, 7210TSPm1, mutated in the EGR1/ WT1 site, displaced the C1 complex but failed to disrupt the C2 one (Figure 4a, lane 4) . Conversely, the m2 mutation allowed displacement of the C2 but not the C1 complex (Figure 4a, lane 3) .
The m1 mutation should aect the binding of both EGR1 and WT1. To determine the nature of the protein binding to the 7210TSP1 region in response to c-Jun, we also performed gel shift experiments using a consensus EGR1 oligonucleotide as a probe. Nuclear proteins from mock cells formed a speci®c complex, C3, with this probe (Figure 4c ). Binding seemed to be better for the consensus EGR1 than for the 7210TSP1 sequence and was reduced by c-Jun expression. These ®ndings suggested that WT1, and not EGR1, could be the protein whose binding to TSP1 promoter is induced by c-Jun overexpression. To test this hypothesis, supershift experiments were performed with antibodies directed against WT1, EGR1, c-Jun and SP1. The anti-SP1 antibody produced a supershift of the C1 band (Figure 4b, lane 9) , con®rming that SP1 participates in this complex. With some batches of protein ( Figure  4b ), a bandshift comigrated with C1; this complex is most likely non speci®c as it is not completely displaceable by the probe itself, the SP1 oligonucleotide or by the anti-SP1 antibody. No supershift was observed with anti-c-Jun antibodies (Figure 4b, lane 8) , in the presence or absence (not shown) of SP1 competitor oligonucleotide, indicating that c-Jun does not participate in any of the complexes and that all the repressive eect of this oncogene on TSP1 occurs through an indirect mechanism. The anti-EGR1 antibodies failed to supershift the C2 complex ( Figure  4b, lane 7) . In contrast, the anti-WT1 antibodies strongly impaired C2 complex formation (Figure 4b , lane 6). This result clearly establishes that c-Jun overexpression enhances the binding of WT1 to the 7210TSP1 promoter region.
The same anti-WT1 antibody was used to detect the WT1 protein in the nuclear extracts used for the EMSA experiments. A 52 kDa band was detected in mock-and c-Jun-transfected REF cells. The amount of WT1 was comparable in these two extracts (Figure 4d ).
Transcription of TSP1 is repressed by WT1
To verify that the binding of WT1 to the TSP1 promoter was responsible for the repression caused by c-Jun, we cotransfected a (7483 to +47) TSP1 ± SEAP construct, alone or with increasing concentrations of expression vectors for either c-Jun, EGR1, WT1+KTS or WT17KTS into FR3T3. EGR1 failed to inhibit TSP1 transcription signi®cantly (Figure 5a ). In contrast, c-Jun, WT1+KTS and WT17KTS strongly aected the expression of the reporter (25+12%, 17+8% and 12+3% of control level respectively at the highest doses of expression vectors). The WT17KTS isoform was the more eective in repressing TSP1 promoter: 50 ng of the expression vector was sucient to repress 50% of the reporter activity while the same dose of the WT1+KTS expression vector did not induce any repression (Figure 5a ).
To verify that the proximal 779 EGR1 site did not play a role in these eects, we repeated the same experiment with a reporter construct which lacked this site (7483 to +47, D784 to 758) TSP1 ± SEAP, and obtained similar results (data not shown). We then introduced, in the context of this vector, the same m1 and m2 mutations that were used previously in gel-shift experiments (see legend to Figure 4) . The basal transcription level was too low to be detectable in the m2 mutant, indicating that SP1 must participate in basal transcription of TSP1 (Figure 5b ). The m1 mutation reduced transcription to about one half of that with the wild type reporter. The residual transcription was no longer inhibitable by WT1 (Figure 5b ) or c-Jun (not shown), indicating that the repression of TSP1 by WT1 requires the integrity of the WT1 binding site.
In addition, the eect of WT1 expression on the steady state level of TSP1 mRNA was assessed by 
Discussion
In a previous study, we have shown that the protooncogene c-Jun regulates the synthesis of thrombospondin 1, a major anti-angiogenic molecule (Mettouchi et al., 1994) . To better understand the role of TSP1 in c-Jun-induced transformation, we focused our attention on transcriptional regulation of TSP1 by c-Jun.
Experimentally, c-Jun activation can result from: (i) overexpression of the protein by transfection of an expression vector; (ii) direct activation of c-Jun binding to DNA by treatment of cells with TPA, which leads via the protein kinase C pathway to the dephosphorylation of serine/threonine residues located close to the DNA binding domain; (iii) stimulation of c-Jun transactivation domain by treatment of the cells with anisomycin, resulting in an induction of JNK/SAPK which hyperphosphorylates the c-Jun transactivation domain. All these three modes of activation of c-Jun lead to a similar repression of TSP1, suggesting that this repression is linked to transcriptional transactivation by c-Jun and indicating that the endogenous level of c-Jun protein is sucient to trigger this response.
The GCN4 yeast transcription factor, which is able to bind and transactivate genes, such as collagenase, that contain an AP1 site in their promoters (Struhl, 1987) , cannot serve as a substitute for c-Jun in repressing TSP1 transcription, and does not induce the secretion of the factor involved in this mechanism. Interestingly, this DNA-binding protein is unable to transform cells, alone or in cooperation with another oncogene. Overexpression of c-Jun, which is by itself able to transform FR3T3 cells but not REF cells, represses TSP1 transcription in both cell types. Other oncogenes can transform ®broblastic cell lines; transformation by c-Myc (Tikhonenko et al., 1996) or polyoma mT (Mettouchi et al., 1994) is also accompanied by the repression of TSP1 expression, while transformation by the bovine papilloma viral oncogenes (RV145-4 cell line) does not. It therefore appears that TSP1 repression is not a general side eect of transformation.
We previously reported that a secreted factor was implicated in TSP1 repression by c-Jun since conditioned medium from REF cells transiently transfected by c-Jun induced the repression of the TSP1 transcription in naive cells (Mettouchi et al., 1994) . We show in this study that the conditioned medium from ®broblasts transformed by c-Jun, such as the cJ4 cells (CM-cJ4), is also able to do so. The repression level is similar to that obtained by transfection of c-Jun or treatment with anisomycin. In contrast, conditioned medium from a transformed cell line, which still expresses high levels of TSP1, like RV145-4, failed to repress TSP1 transcription. During the course of treating FR3T3 cells with CM-cJ4 and measuring TSP1 repression, we observed that CM-cJ4 is mitogenic for FR3T3 cells. In addition, FR3T3-treated cells get smaller, reorganize their actin and vimentin cytoskeleton, and lose cell contact inhibition (data not shown). We observed that the TSP1 repression and these cellular phenomena were enhanced by acidi®cation of the CM-cJ4. As some growth factors could be activated by a proteolytic cleavage that acidi®cation can mimic in vitro, we tested several growth factors (TGFb1, PDGF, bFGF, aFGF, EGF, VEGF, FIGF/VEGF-D) and proteases (cathepsins B and D) but none could repress TSP1 promoter activity. The puri®cation of the active factor, which is in progress, should enable us to determine if a single molecule is responsible for these cellular eects and TSP1 repression, and shed additional light on the pathways involved.
The dierential responsiveness of serial deletions of the TSP1 promoter to c-Jun indicates that TSP1 repression by c-Jun utilizes a transcriptional mechanism which does not involve any of the canonical AP1 sites present in the TSP1 promoter. We identi®ed a 105 bp region, (7239 to 7135) which was sucient to confer the capacity to be repressed by c-Jun transfection or by CM-cJ4 when linked to a minimal thymidine kinase heterologous promoter. This region was speci®cally recognized by nuclear extracts in EMSA and the protein binding site could be restricted to 22 nucleotides centered on the 7210 position in the TSP1 promoter. Comparison of this sequence with transcription factor data banks indicated that three zinc ®nger proteins, SP1, EGR1, and WT1, could theoretically bind to this site. Overlapping SP1 and EGR1 sites are frequent, but overlapping WT1/EGR1/ 
Repression of thrombospondin 1 expression by WT1
V Dejong et al SP1 sites are much less often found in eukaryotic promoters. Analysis of these 22 bp by gel shift analysis indicated that SP1 binding was constitutive on this site and that c-Jun induced the binding capacity of WT1 while EGR1 did not bind. Supershift experiments with anti-WT1 and anti-EGR1 antibodies con®rmed these results.
To correlate the binding of WT1 to the TSP1 promoter with the transcriptional repression of TSP1, the eect of EGR1 and WT1 on TSP1 reporter activity was determined in REF cells. EGR1 did not aect signi®cantly the reporter gene expression. In contrast, the two isoforms of WT1 were active in repressing the TSP1 promoter, although at low WT1 concentrations, the 7KTS isoform was more eective than the +KTS one. Mutation of the distal nucleotides of the 7210 site abolished the TSP1 transcriptional repression by cJun or WT1, and mutation of the nucleotides implicated in SP1 binding abolished the basal transcription level. Taken together, these results establish that WT1 is the protein that binds to the TSP1 promoter in response to c-Jun overexpression and mediates TSP1 transcriptional repression. Although WT17KTS is often reported to bind to the same DNA elements as EGR1, EGR1 was unable to repress transcription of TSP1.
The repression of TSP1 induced by c-Jun transfection was not aected by protein synthesis inhibitors, and WT1 protein levels were similar in control and cJun transfected cells. Therefore, post-translational modi®cations of endogenous WT1 are likely to be responsible for its binding to the TSP1 promoter in response to c-Jun. Although we could not observe any modi®cation in migration of WT1 protein between control and c-Jun transfected cells, these modi®cations could be a dephosphorylation of WT1 as phosphorylation of this transcription factor has been reported to inhibit its binding to DNA (Ye et al., 1996) . The phosphorylation sites were recently located to Ser-365 and Ser-393 in the zinc ®nger domain of WT1 (Sakamoto et al., 1997) .
In our cellular model, TSP1 clearly has antineoplastic properties, as re-expression of TSP1 in cJ4 cells reduces their tumorigenicity in vivo (Filleur et al., in preparation) . WT1 was discovered as a consequence of its tumor suppressor properties in the kidney. Its capacity to repress TSP1 in response to c-Jun activation is not in keeping with this property and indicates that WT1 could, at least in response to another oncogene, be directly involved in transformation, favoring the development of a tumor by in¯uencing the extracellular matrix environment. Oncogenic properties have also been assigned to WT1 in other cellular models: WT17KTS enhances the in vivo tumorigenicity of adenovirus-transformed baby rat kidney cells (Menke et al., 1996) . High levels of nonmutated forms of WT1 have been reported to be expressed in human melanomas (Rodeck et al., 1994) , acute leukemias (Svedberg et al., 1998) and rat mesotheliomas (Kleymenova et al., 1998) whereas none was not detectable in normal cells. Constitutive expression of WT1 in a monoblastic cell line leads to impairment of dierentiation responses (Svedberg et al., 1998) .
We have shown that, in REF cells, the WT17KTS isoform is more active on the TSP1 promoter than WT1+KTS. Four isoforms of WT1 are synthesized in cells. The balance between these dierent isoforms seems to be tightly controlled and the dierent isoforms may not participate equally in all WT1 functions: the IGF2 promoter is activated by WT17KTS and repressed by the WT1+KTS isoform (Duarte et al., 1998) . In vitro, the repression of the insulin receptor by WT17KTS requires the presence of either C/EBP beta or of a dominant negative form of p53 (Webster et al., 1997) . WT1 and p53 can interact physically (Maheswaran et al., 1993) , and this interaction modulates their biological activities . p53 has been shown to positively regulate TSP1 synthesis (Dameron et al., 1994) but the promoter region responsible for this regulation has not been identi®ed. In this respect, it would be interesting to determine if p53 modulates the capacity of WT1 to repress TSP1 transcription.
We conclude that c-Jun does not participate directly in repression of TSP1 by binding to its promoter but that this eect is mediated by a secreted factor. This factor triggers a signal transduction pathway which activates the binding of WT1 to the 7210 region of TSP1 promoter, and leads to the transcriptional repression of this gene. This mechanism spreads the signal around cells overexpressing c-Jun thus lowering TSP1 expression in the neighboring cells. The transduction pathway that activates WT1 could also function on other genes with similar cis-acting elements in their promoters. According to this hypothesis, c-Jun activation in a single cell could not only repress TSP1 in neighboring cells, but also coordinate the activation or repression of a set of genes, some of which could participate in the transformation process or in the development of a tumor.
Materials and methods
Cell culture and conditioned medium REF cells were prepared, cultured and transfected as previously described (BineÂ truy et al., 1991) . FR3T3, cJ4 and RV145-4 cells (Mettouchi et al., 1994) were cultured in DMEM medium (Biological Industries) supplemented with 10% newborn bovine serum (NBS, Biological Industries). To collect conditioned medium, cells were plated for 2 days in DMEM with 10% NBS. Medium was then replaced with DMEM with 0.5% serum, collected 2 ± 4 days later, ®ltered through 0.4 mm ®lters and stored at 48C. Conditioned media (CM) were used diluted 1 : 2 with fresh DMEM plus 0.5% NBS.
Transfection experiments, reporter assays and Northern blot analysis
Cells were transfected by the calcium phosphate precipitation method as previously described (Mettouchi et al., 1994) . The expression vectors used were: pRSV-c-Jun (BineÂ truy et al., 1991), pCMV ± KROX24 for EGR1 (Kramer et al., 1994) , pCMV(WT17KTS) and pCMV(WT1+KTS) for the WT1 isoforms. Mock transfections were performed using an empty expression vector or a CMV ± EGFP plasmid. Cells were transfected overnight, washed, and refed with fresh medium. Analysis of reporter activities or Northern blots were performed 24 h later. When a puromycin selection vector was cotransfected, cells were allowed to recover for 6 h after transfection before the addition of the drug (5 mg/ml) for the next 24 h. The percentage of EGFP-expressing cells was determined by observation of the cells under a¯uorescence microscope.
SEcreted Alkaline Phosphatase (SEAP) was assayed 24 h after transfection of cells with the reporter plasmid in 30 ml of cell culture medium using a sensitive luminometric assay (Phosphalight, ICN). Luciferase activity was measured on cell lysates. To test conditioned media, reporter constructs were transfected into FR3T3 cells overnight, and the cells then split into 24-well culture plates in DMEM with 0.5% NBS, diluted 1 : 2 or not with conditioned media. Reporter activity was measured 24 h later.
For Northern blot analysis, transfected cells were collected 24 h after transfection. Total RNA was prepared according to Chomczinsky and Sacchi (1987) , 5 mg of total RNA per lane was blotted onto nylon membranes (Biotrans, ICN), cross-linked with UV and hybridized to radiolabeled probes synthesized from puri®ed cDNA inserts. The hybridization signals were quanti®ed with a phosphorimager (Storm, Molecular Dynamics). Equal loading of RNA was controlled by hybridization with a probe directed against S26 ribosomal protein RNA (Vincent et al., 1993) .
Vector constructions and mutagenesis
TSP ± SEAP reporter vectors were constructed by cloning the BamHI ± SphI (72800 to +47) mouse promoter region of TSP1 (Bornstein et al., 1990) or shorter restriction fragments in the pSEAP basic vector (Clontech). The (7239 to 7135) Eco47III ± AvaI fragment was cloned 5' to a minimal HSV ± TK promoter driving the luciferase coding sequence. Mutations were introduced into vectors using oligonucleotides and the Gene Editor kit (Promega Biotech). The mutated oligonucleotides that were used have the same sequence as those used in EMSA experiments. Mutations were veri®ed by sequencing with the dideoxynucleotide sequencing method.
Electrophoretic mobility shift assays and Western blot analysis REF cells were transfected and collected 24 h after transfection and nuclear extracts were prepared as described (Desbois et al., 1991) . Electrophoretic mobility shift assays were performed by incubating 4 mg of nuclear extract with 1 mg of poly (dI.dC) in 10 ml ®nal volume containing glycerol 5% (v/v), EDTA 0.5 mM, DTT 0.5 mM, NaCl 50 mM, TrisHCl 10 mM, pH 7.5, BSA 100 mg/ml, for 15 min at 258C. Non-labeled competitors (4 pmol) or antiserum (1 mg) were added at the same time. Forty fmoles of 5' 32 P-labeled double-stranded oligonucleotide was added and incubated for ten more minutes at 258C. Samples were fractionated by electrophoresis through a 5% 29 : 1 acrylamide/bisacrylamide gel run in 45 mM Tris base, 45 mM boric acid and 5 mM EDTA. The sequences of the sense strand of the oligonucleotides used are shown in the legend to Figure 4 . Supershift experiments were performed with a polyclonal anti-c-Jun antiserum directed against the c-Jun DNA binding domain (Chiu et al., 1988) , a polyclonal anti-WT1 (C19, Santa Cruz Biotechnology, USA) or monoclonal antibodies directed against EGR1 or SP1 (Santa Cruz Biotechnology). For Western blot analysis of WT1 protein, nuclear protein extracts (120 mg) were diluted in Laemmli sample buer, resolved by electrophoresis through a 10% SDS ± acrylamide gel and blotted onto a PVDF membrane (Hybond P, Amersham). After blocking with skim milk, the membrane was incubated with 5% skim milk and C19 anti-WT1 antibody diluted 1/1000 or with a non-relevant polyclonal antibody at the same dilution for 1 h at room temperature. After three washes in PBS ± 0.05% Tween 20, the membrane was incubated with a horseradish peroxidase-conjugated goat anti-rabbit antibody diluted 1/2000 (Biorad) for 1 h at room temperature. After three washes with PBS ± 0.05% Tween 20, WT1 protein was detected by the ECL-plus detection system (Amersham) on a Storm imager (Molecular Dynamics) setted on blue¯uorescence, 650 V, as indicated (Amersham, Tech Tip 173).
